Patents

Botulinum Neurotoxin (BoNT)

The Botulinum Neurotoxin (BoNT) works on the neuromuscular junction. This electron micrograph shows a cross section of the neuromuscular junction. T is the axon terminal, M is the muscle fiber. Source: National Institutes of Mental Health.

Synaptic Research holds several patents either through assignment or through exclusive licenses. The company also has several patents pending.  Following are links to several of these patents or applications:

  1. Methods for Identifying Inhibitors of Botulinum Neurotoxins
  2. Fusion Proteins that Specifically Inhibit Protein Synthesis in Neuronal Cells (not yet available online)